You are here: Industry Insights > UK

News List

UK launch for progressive multiple sclerosis mega-trial pharmatimes
May 08, 2021
The MS Society had announced that a world-first mega-trial for progressive multiple sclerosis (MS) will be launched in the UK later this year.
Serum Institute of India to make £240 mn investments in UK expresspharma
May 07, 2021
Serum’s investment will support clinical trials, research and development and possibly manufacturing of vaccines.
UK buys another 60 million doses of Pfizer/BioNTech vaccine pharmatimes
May 06, 2021
The UK government has secured an extra 60 million doses of Pfizer/BioNTech’s COVID-19 vaccine, in a bid to strengthen plans for the autumn COVID-19 vaccination programme.
How COVID-19 impacted UK healthcare worldpharmanews
April 28, 2021
Just one third of people in the UK managed to access the hospital care they needed at the peak of the first wave of the Covid-19 pandemic - according to new research from the University of East Anglia.
UK government launches search for at-home COVID-19 treatments pharmatimes
April 22, 2021
The UK government has launched a new Antivirals Taskforce in a bid to identify promising home treatments for people who have been exposed to COVID-19.
New subcutaneous formulation of Tysabri approved in UK pharmatimes
April 19, 2021
The Medicines and Healthcare products Regulatory Agency (MHRA) has approved a new subcutaneous (SC) formulation for Biogen’s multiple sclerosis treatment Tysabri.
Sartorius Expands in the UK contractpharma
April 19, 2021
Sartorius will open a new state-of-the-art manufacturing facility in Havant, Hampshire, UK. More than 90 employees will relocate to the new facility near the former site in Portsmouth.
Post-Brexit point-based immigration system will affect the UK’s healthcare system: Poll pharmaceutical-technology
April 16, 2021
The UK government commenced taking applications for the new Skilled Worker Visa from January 2021, based on the new post-Brexit points-based visa and immigration system.
Fund opens to boost UK life sciences manufacturing pharmatimes
April 08, 2021
Life science companies can now apply for a share of £20 million to expand manufacturing of medicines, diagnostics and med tech in the UK.
UK starts administering Moderna vaccine against COVID-19 expresspharma
April 08, 2021
The UK began the rollout of the Moderna vaccine to protect against COVID-19, the third two-dose vaccine now being administered by the National Health Service (NHS) alongside the Pfizer/BioNTech and Oxford/AstraZeneca jabs.

Previous page 1 2 3 4 5 6 7 8 9 10 ... 29 30 Next page